Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.

A B C D E F G I J K L M N O P R S T U V X Z

Zykadia™

ceritinib

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Zortress®/Certican®

everolimus

Immunology and Dermatology

Global Product Site USA Product Site USA Germany Australia United Kingdom Austria Poland Netherlands Turkey

Zometa®

zoledronic acid

Oncology

USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Xolair®

omalizumab

Immunology and Dermatology

Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Votrient®

pazopanib

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Voltaren®/Cataflam®

diclofenac sodium, potassium, resinate, free acid

Autoimmunity, Transplantation & Inflammatory Disease

Established Medicines

Global Product Site Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Ultibro® Breezhaler®

indacaterol, glycopyrronium bromide

Respiratory

Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Tyzeka®/Sebivo™

telbivudine

Infectious disease

Established Medicines

Global Product Site USA Germany United Kingdom Poland Canada Turkey

Tyverb®

lapatinib

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Canada Turkey Japan

Trileptal®

oxcarbazepine

Neuroscience

Established Medicines

Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Travatan® BAK-Free

travoprost

Ophthalmology

Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan®

travoprost

Ophthalmology

Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Travatan Z®

travoprost

Ophthalmology

Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Tobradex®

tobramycin, dexamethasone

Ophthalmology

USA Germany Austria Poland Netherlands Canada

TOBI® Podhaler™

tobramycin

Respiratory

Established Medicines

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

TOBI®

tobramycin

Respiratory

Established Medicines

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Tegretol®

carbamazepine

Neuroscience

Established Medicines

Global Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Tasigna®

nilotinib

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Tafinlar®

dabrafenib

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Systane® Ultra

polyethylene glycol 400, propylene glycol

Ophthalmology

Global Product Site

Systane® Hydration

polyethylene glycol 400, propylene glycol, hyaluronic acid

Ophthalmology

Global Product Site

Systane® Balance

propylene glycol

Ophthalmology

Global Product Site

Systane®

polyethylene glycol 400, propylene glycol

Ophthalmology

Global Product Site

Stalevo®

carbidopa, levodopa, entacapone

Neuroscience

Established Medicines

Global Product Site USA Australia Austria Netherlands Canada Turkey Japan

Simulect®

basiliximab

Immunology and Dermatology

Global Product Site USA Finland Germany United Kingdom Austria Poland Netherlands Canada Turkey

Simbrinza®

brinzolamide, brimonidine tartrate

Ophthalmology

Global Product Site USA Germany Australia Austria Poland Netherlands Canada

Signifor® LAR

pasireotide

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Signifor®

pasireotide

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Seebri Breezhaler®

glycopyrronium bromide

Respiratory

Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Japan

Sandostatin® SC

octreotide acetate

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Sandostatin LAR®

octreotide acetate

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Poland Netherlands Canada Turkey Japan

Rydapt®

midostaurin

Oncology

Global Product Site USA Product Site

Ritalin®

methylphenidate HCl

Neuroscience

Established Medicines

Global Product Site USA Finland Germany Australia United Kingdom Austria Netherlands Canada Turkey Japan

Ritalin LA®

methylphenidate HCl modified release

Neuroscience

Established Medicines

USA Australia

Promacta®/Revolade®

eltrombopag

Oncology

Global Product Site USA Product Site USA Finland Germany Australia Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Canada Turkey Japan

Proleukin®

aldesleukin

Oncology

USA Product Site Germany United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Netherlands Canada Turkey

Piqray®

alpelisib

Oncology

USA Product Site USA

Pazeo®

olopatadine

Ophthalmology

Global Product Site USA Canada

Patanol®

olopatadine

Ophthalmology

Global Product Site USA Product Site USA Australia Poland Netherlands Canada Japan

Pataday™

olopatadine

Ophthalmology

Global Product Site USA Canada

Onbrez® Breezhaler®

indacaterol

Respiratory

Finland Germany Australia United Kingdom Poland Netherlands Canada Turkey Japan

Neoral®/Sandimmune®

cyclosporine, USP Modified

Immunology and Dermatology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Myfortic®

mycophenolic acid (as mycophenolate sodium)

Immunology and Dermatology

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey

Mekinist®

trametinib

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Mayzent®

siponimod

Neuroscience

USA Product Site USA

Luxturna®

voretigene neparvovec

Ophthalmology

USA Product Site USA

Lucentis®

ranibizumab

Ophthalmology

Global Product Site Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Lescol® XL

fluvastatin sodium

Cardiovascular, Renal and Metabolism

Established Medicines

Global Product Site USA Australia United Kingdom Austria Poland Netherlands Canada

Lescol®

fluvastatin sodium

Cardiovascular, Renal and Metabolism

Established Medicines

Global Product Site USA Australia United Kingdom Austria Poland Netherlands Canada

Lamisil®

terbinafine (terbinafine hydrochloride)

Infectious disease

Established Medicines

USA Germany Australia United Kingdom Poland Canada Turkey

Kymriah™

tisagenlecleucel-T

Oncology

Global Product Site USA Product Site

Kisqali®

ribociclib

Oncology

Global Product Site USA Product Site

Jakavi®

ruxolitinib

Oncology

Global Product Site Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Jadenu®

deferasirox

Oncology

Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Izba®

travoprost

Ophthalmology

Global Product Site USA Germany Australia Austria Poland Netherlands Canada Japan

Ilevro®/Nevanac®

nepafenac

Ophthalmology

Global Product Site Germany Canada Australia Austria Poland Netherlands USA

Ilaris®

canakinumab

Immunology and Dermatology

USA Product Site USA Germany United Kingdom Austria Poland Netherlands Canada Turkey Japan

Gleevec®/Glivec®

imatinib mesylate

Oncology

Global Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Gilenya®

fingolimod

Neuroscience

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Japan

Galvus®

vildagliptin

Cardiovascular, Renal and Metabolism

Established Medicines

Global Product Site Finland Australia United Kingdom Austria Poland Netherlands Turkey

Focalin® XR

dexmethylphenidate HCl, dexmethylphenidate extended release

Neuroscience

Established Medicines

USA Product Site USA

Focalin®

dexmethylphenidate HCl, dexmethylphenidate extended release

Neuroscience

Established Medicines

USA Product Site USA

Femara®

letrozole

Oncology

USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Netherlands Canada Turkey Japan

Farydak®

panobinostat

Oncology

Global Product Site USA Germany Novartis Oncology Netherlands Austria Poland Netherlands

Extavia®

interferon beta-1b

Neuroscience

USA Product Site USA Finland Germany United Kingdom Poland Canada

Exjade®

deferasirox

Oncology

Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Exforge®

valsartan, amlodipine besylate

Cardiovascular, Renal and Metabolism

Established Medicines

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Turkey

Exforge HCT®

valsartan, amlodipine besylate, hydrochlorothiazide

Cardiovascular, Renal and Metabolism

Established Medicines

USA Product Site USA Finland Germany Australia Austria Poland Turkey Japan

Exelon®

rivastigmine

Neuroscience

Established Medicines

USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Eucreas®

vildagliptin, metformin

Cardiovascular, Renal and Metabolism

Respiratory

Global Product Site Finland United Kingdom Austria Poland Netherlands

Entresto®

sacubitril, valsartan

Cardiovascular, Renal and Metabolism

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Egaten®

triclabendazole

Hepatology

Established Medicines

USA

Durezol®

difluprednate

Ophthalmology

Global Product Site USA Canada

Duotrav™

travoprost, timolol

Ophthalmology

Germany Australia Austria Poland Netherlands Canada Japan

Diovan®

valsartan

Cardiovascular, Renal and Metabolism

Established Medicines

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Turkey Japan

Diovan HCT® /Co-Diovan®

valsartan, hydrochlorothiazide

Cardiovascular, Renal and Metabolism

Established Medicines

USA Product Site USA Finland Austria Poland Netherlands Canada Turkey

Cosentyx®

secukinumab

Immunology and Dermatology

USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Comtan®

entacapone

Neuroscience

Established Medicines

Global Product Site USA Australia Netherlands Canada Turkey Japan

Ciprodex®

ciprofloxacin, dexamethasone

Ophthalmology

Global Product Site Canada USA

Cibacen®

benazepril hydrochloride

Cardiovascular, Renal and Metabolism

Established Medicines

Beovu®

brolucizumab

Ophthalmology

Global USA

Azarga®/Azorga®

brinzolamide, timolol

Ophthalmology

Germany Australia Austria Poland Netherlands Canada Japan

Arzerra®

ofatumumab

Oncology

Global Product Site USA Product Site USA Finland Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Aimovig®

erenumab

Neuroscience

USA Product Site USA

Afinitor®/Votubia®

everolimus

Oncology

Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey

Afinitor Disperz®/Votubia®

everolimus

Oncology

Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey